Trials / Sponsors / N.N. Blokhin National Medical Research Center of Oncology
N.N. Blokhin National Medical Research Center of Oncology
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Osimertinib for Russian EGFR T790M Mutation-positive NSCLC Patients Who Progressed on or After EGFR TKI Therap Non Small Cell Lung Cancer, T790M, EGFR Gene Mutation | — | 2020-06-01 |